[1]
Rahman, T. et al. 2022. Toxicities Associated With Dose-Adjusted Epoch-R Compared With R-Chop as Frontline Therapy for Diffuse Large B-Cell Lymphoma: A Study Conducted in a Tertiary Level Hospital of Bangladesh. Bangladesh Journal of Medicine. 33, 2 (Apr. 2022), 161–167. DOI:https://doi.org/10.3329/bjm.v33i2.59289.